Sibrand Poppema

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity

Ekkehard Mössner, Peter Brünker, Samuel Moser et al. · Blood · 2010 · 957 citations · Full text

Life Sciences, Immunology, Oncology +17

BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas

Joost Kluiver, Sibrand Poppema, Debora de Jong et al. · The Journal of Pathology · 2005 · 675 citations · Full text

Medicine, Hematology, Oncology +13

Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer

Klaas Kok, Jan Osinga, B. Carritt et al. · Nature · 1987 · 394 citations

Life Sciences, Genetics, Molecular Genetics +14

European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.

Ioannis Anagnostopoulos, Martin‐Leo Hansmann, Kaarle Franssila et al. · PubMed · 2000 · 282 citations

Medicine, Oncology, Pathology +14

Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections.

Sibrand Poppema, Harry Hollema, Lydia Visser et al. · PubMed · 1987 · 234 citations

Medicine, Immunology, Pathology +16